Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repurposing selective serotonin reuptake inhibitors for severity of COVID-19: A population-based study
Irene Visos‐Varela, Maruxa Zapata‐Cachafeiro, María Piñeiro‐Lamas, et al.
European Neuropsychopharmacology (2023) Vol. 71, pp. 96-108
Open Access | Times Cited: 13

Showing 13 citing articles:

Assessing the effect of selective serotonin reuptake inhibitors in the prevention of post-acute sequelae of COVID-19
Hythem Sidky, Kristen Hansen, Andrew T. Girvin, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 24, pp. 115-125
Open Access | Times Cited: 15
Post-infectious irritable bowel syndrome: Focus on serotonin metabolism disturbances and gut microbiota modulation
О. В. Гаус, Aliza Fedorenko, А. Н. Судакова
Medical alphabet (2025), Iss. 34, pp. 36-41
Closed Access
COVID-19 in the years 2020 to 2022 in Germany: effects of comorbidities and co-medications based on a large-scale database analysis
Roland Linder, Jonas Peltner, A. Astvatsatourov, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Could antidepressants increase mood and immunity at the same time?
Francis Lavergne, Thérèse M. Jay
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Specific adverse outcomes associated with selective serotonin reuptake inhibitors use in COVID-19 patients might be potentiated by remdesivir use
Ivan Papic, Petra Bistrović, Ivan Krečak, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 4, pp. 395-403
Closed Access | Times Cited: 2
Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient
Rosa María García-Álvarez, Maruxa Zapata‐Cachafeiro, Irene Visos‐Varela, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 3, pp. 1805-1815
Open Access | Times Cited: 1
The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study
Narmeen Mallah, Irene Visos‐Varela, Bahi Takkouche, et al.
Inflammopharmacology (2024)
Open Access | Times Cited: 1
Die Bedeutung von Antidepressiva bei COVID-19 und Long-COVID – Ein Scoping-Review Update
Udo Bonnet, Georg Juckel
Fortschritte der Neurologie · Psychiatrie (2024)
Closed Access | Times Cited: 1
Gastrointestinal pathophysiology in long COVID: Exploring roles of microbiota dysbiosis and serotonin dysregulation in post-infectious bowel symptoms
Linda Chia‐Hui Yu
Life Sciences (2024) Vol. 358, pp. 123153-123153
Open Access | Times Cited: 1
Anxiety in post-covid-19 syndrome – prevalence, mechanisms and treatment
Julius Burkauskas, Igor Branchi, Stefano Pallanti, et al.
Neuroscience Applied (2023) Vol. 3, pp. 103932-103932
Open Access | Times Cited: 2
Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study
Almudena Rodríguez-Fernández, Irene Visos‐Varela, Maruxa Zapata‐Cachafeiro, et al.
Inflammopharmacology (2024)
Open Access
Negative Prognostic Associations of Selective Serotonin Reuptake Inhibitors Use in Hospitalized COVID-19 Patients and Potential Contribution of Cardiovascular Comorbidities
Ivan Papic, Petra Bistrović, Ivan Krečak, et al.
Pharmacology (2024), pp. 1-8
Closed Access
SSRIs in the course of COVID‐19 pneumonia: Evidence of effectiveness of antidepressants on acute inflammation. A retrospective study
Leonardo Fei, Bernardo Bozza, Giulia Melani, et al.
Human Psychopharmacology Clinical and Experimental (2023)
Closed Access | Times Cited: 1
Page 1

Scroll to top